Transcription of Press Release - drreddys.com
{{id}} {{{paragraph}}}
Example: tourism industry
Press Release - drreddys.com
Press Release CONTACT. DR. REDDY'S LABORATORIES LTD. INVESTOR RELATIONS MEDIA RELATIONS. 8-2-337, Road No. 3, Banjara Hills, SAUNAK SAVLA CALVIN PRINTER. Hyderabad - 500034. Telangana, India. (Ph: +91-40-49002135) (Ph: +91-40- 49002121).. Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the Market Hyderabad, India, June 15, 2018 For Immediate Release .. Hyderabad, India and Princeton, NJ, USA. June 15, 2018 Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has received final approval from the Food and Drug Administration (USFDA) and is launching Buprenorphine and Naloxone Sublingual Film, 2 mg, 4 mg/1 mg, 8.
An overdose and even death can happen if you take benzodiazepines, sedatives, tranquilizers, antidepressants, or alcohol while using Buprenorphine and …
Loading..
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: